Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Accenture
Harvard Business School
Chubb
Baxter
Federal Trade Commission
Fish and Richardson
Cantor Fitzgerald
Deloitte

Generated: February 19, 2018

DrugPatentWatch Database Preview

TOLAZAMIDE Drug Profile

« Back to Dashboard

Which patents cover Tolazamide, and when can generic versions of Tolazamide launch?

Tolazamide is a drug marketed by Barr, Duramed Pharms Barr, G And W Labs Inc, Interpharm, Mylan Pharms Inc, Par Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, Watson Labs, and Yaopharma Co Ltd. and is included in thirty NDAs.

The generic ingredient in TOLAZAMIDE is tolazamide. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the tolazamide profile page.
Drug patent expirations by year for TOLAZAMIDE
Pharmacology for TOLAZAMIDE
Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Medical Subject Heading (MeSH) Categories for TOLAZAMIDE

US Patents and Regulatory Information for TOLAZAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Yaopharma Co Ltd TOLAZAMIDE tolazamide TABLET;ORAL 070289-001 Mar 13, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TOLAZAMIDE tolazamide TABLET;ORAL 070514-001 Jan 9, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Yaopharma Co Ltd TOLAZAMIDE tolazamide TABLET;ORAL 070290-001 Mar 13, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TOLAZAMIDE tolazamide TABLET;ORAL 070244-001 Aug 1, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr TOLAZAMIDE tolazamide TABLET;ORAL 070162-001 Jan 14, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries TOLAZAMIDE tolazamide TABLET;ORAL 071358-001 Jul 16, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Usl Pharma TOLAZAMIDE tolazamide TABLET;ORAL 070169-001 Apr 2, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs Inc TOLAZAMIDE tolazamide TABLET;ORAL 018894-001 Nov 2, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Duramed Pharms Barr TOLAZAMIDE tolazamide TABLET;ORAL 070165-001 Jan 10, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc TOLAZAMIDE tolazamide TABLET;ORAL 070259-001 Jan 2, 1986 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
Dow
US Army
Chinese Patent Office
Federal Trade Commission
QuintilesIMS
AstraZeneca
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot